Loading clinical trials...

Purpose of This Study is to Evaluate the Safety and Efficacy of One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma Subjects | Clinical Trials | Clareo Health

COMPLETEDNA

Purpose of This Study is to Evaluate the Safety and Efficacy of One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma Subjects

A Prospective, Randomized, Controlled Evaluation of Open-Angle Glaucoma Subjects on Two Topical Hypotensive Medications, Implanted With One, Two, or Three Trabecular Micro-Bypass Stents

NCT01252849•Glaukos Corporation

View on ClinicalTrials.gov

Summary

The purpose of this study is to evaluate the safety and efficacy of the iStent medical device that is implanted into the eye and designed to reduce eye pressure in patients with your condition.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Diagnosed with primary open-angle glaucoma (POAG)
•Subject on two topical hypotensive medications

Exclusion Criteria

•Traumatic, uveitic, neovascular, or angle closure glaucoma
•Fellow eye already enrolled

Locations (1)

S.V. Malayan's Ophthalmology Centre

Yerevan, Armenia

Key Dates

Start Date

December 1, 2010

Primary Completion Date

October 8, 2019

Completion Date

October 8, 2019

Last Updated

August 31, 2022

Enrollment

119

ACTUAL participants

Conditions

Primary Open Angle Glaucoma (POAG)

Interventions

iStent

DEVICE

iStent

DEVICE

iStent

DEVICE

Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery

NCT01085357

Primary Open Angle Glaucoma (POAG)Cataract

View study

COMPLETEDNA

Study of CyPass Implantation In Patients With Open Angle Glaucoma Refractory to Single or Multi-agent Topical Therapy

NCT01166659

Primary Open Angle Glaucoma (POAG)

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 31, 2022Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Purpose of This Study is to Evaluate the Safety and Efficacy of One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma Subjects

Inclusion Criteria

Exclusion Criteria

Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery

Study of CyPass Implantation In Patients With Open Angle Glaucoma Refractory to Single or Multi-agent Topical Therapy

Study to Compare Standard Perimetry With the New Scotoma-Oriented Perimetry (SCOPE) Using a New Fast German Adaptive Threshold Estimation (GATE) in Glaucoma Patients